These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 4540465)

  • 1. Serologic distinction between soluble species-specific and strain-specific transplantation antigens.
    Sachs DH; McKenzie IF; Winn HJ; Russell PS
    Transplant Proc; 1973 Mar; 5(1):477-80. PubMed ID: 4540465
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-reactivity between HL-A and H-2 antigens. II. Allogeneic sensitization by xenogeneic soluble lymphocyte antigens (HL-A).
    Götze BD; Lee S; Ferrone S; Pellegrino MA; Reisfeld RA
    Transplant Proc; 1973 Mar; 5(1):467-70. PubMed ID: 4572106
    [No Abstract]   [Full Text] [Related]  

  • 3. The immunologic response to xenografts. Recognition of mouse H-2 histocompatibility antigens by the rat.
    Sachs DH; Winn HJ; Russell PS
    J Immunol; 1971 Aug; 107(2):481-92. PubMed ID: 4936290
    [No Abstract]   [Full Text] [Related]  

  • 4. Serologic homology between H-2 and HL-A system.
    David CS; Klein J; Shreffler DC
    Transplant Proc; 1973 Mar; 5(1):461-6. PubMed ID: 4633089
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune response of mice to concanavalin A-coated EL 4 leukemia.
    Martin WJ; Wunderlich JR
    Natl Cancer Inst Monogr; 1972 Dec; 35():295-9. PubMed ID: 4679048
    [No Abstract]   [Full Text] [Related]  

  • 6. Transplantation antigens in the chacma baboon Papio ursinus Kerr.
    Downing HJ; Burgess BJ; Vos GH; Burgers LE; Webb GR
    Transplant Proc; 1974 Jun; 6(2):169-72. PubMed ID: 4275460
    [No Abstract]   [Full Text] [Related]  

  • 7. Passive enhancement of mouse skin allografts. Specificity of the antiserum for major histocompatibility.
    Staines NA; Guy K; Davies DA
    Transplantation; 1974 Aug; 18(2):192-5. PubMed ID: 4602953
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunogenicity of soluble murine histocompatibility antigens.
    Sagi S; Turianskyj FH; Gyenes L
    Immunol Commun; 1974; 3(1):85-94. PubMed ID: 4823533
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of leukemia in rats using a conjugate of specific immunoglobulin and albumin-methotrexate].
    Storek J
    Sb Lek; 1985 May; 87(5):121-7. PubMed ID: 3875893
    [No Abstract]   [Full Text] [Related]  

  • 10. The PLL gene and histocompatibility genotype in inbred and random-bred guinea pigs.
    Ellman L; Green I; Benacerraf B
    J Immunol; 1971 Aug; 107(2):382-8. PubMed ID: 5568769
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppressed development of cytotoxic lymphoid cells in tumor-immunized mice.
    Martin WJ; Wunderlich JR; Macdonald J
    Isr J Med Sci; 1973 Mar; 9(3):324-31. PubMed ID: 4710040
    [No Abstract]   [Full Text] [Related]  

  • 12. The protective effect of antisera against leukaemia in vivo--a reappraisal.
    Hersey P
    Br J Cancer Suppl; 1973 Aug; 1():11-8. PubMed ID: 4807573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HL-A-specific antibodies by immunization of Macaca irus (cynomologous) monkeys with purified HL-A substances.
    Sanderson AR; Welsh KI
    Transplant Proc; 1973 Mar; 5(1):471-5. PubMed ID: 4633090
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytotoxicity of vivo sensitized lymphocytes on allogeneic third-party fibroblasts differing for various regions of the H-2 complex.
    Jorgensen PN; Florentz K; Güttler F
    Transplant Proc; 1974 Mar; 6(1):95-9. PubMed ID: 4817057
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental model for the detection of leukemia-specific antigens in acute leukemias in humans].
    Danilevich SV; Kalinina IA
    Biull Eksp Biol Med; 1983 Jan; 95(1):87-8. PubMed ID: 6187387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the immune response to transplantation antigens. I. The effects of immunization using adjuvants on the immune response of mice to a tumour allograft.
    Zola H
    Clin Exp Immunol; 1972 Aug; 11(4):585-93. PubMed ID: 4563711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of Gross leukemia cell-surface antigens: a kind of antigenic modulation.
    Aoki T; Johnson PA
    J Natl Cancer Inst; 1972 Jul; 49(1):183-92. PubMed ID: 5037434
    [No Abstract]   [Full Text] [Related]  

  • 18. Generation of cytotoxic lymphocytes by SV40-induced antigens.
    Chang C; Chang R; Mora PT; Hu CP
    J Immunol; 1982 May; 128(5):2160-3. PubMed ID: 6278025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of immune factors on the motility of lymphoma cells.
    Cochran AJ; Klein E; Keissling R
    J Natl Cancer Inst; 1972 Jun; 48(6):1657-61. PubMed ID: 4560294
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of tumor and histocompatibility antigens in sera of lymphoma-bearing mice.
    Fujimoto S; Chen CH; Sabbadini E; Sehon AH
    J Immunol; 1973 Oct; 111(4):1093-100. PubMed ID: 4728678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.